Abbott India Limited (NSE:ABBOTINDIA)
29,597
-199 (-0.67%)
Mar 13, 2025, 3:29 PM IST
Abbott India Revenue
Abbott India had revenue of 16.14B INR in the quarter ending December 31, 2024, with 12.33% growth. This brings the company's revenue in the last twelve months to 62.43B, up 8.51% year-over-year. In the fiscal year ending March 31, 2024, Abbott India had annual revenue of 58.49B with 9.35% growth.
Revenue (ttm)
62.43B
Revenue Growth
+8.51%
P/S Ratio
n/a
Revenue / Employee
16.37M
Employees
3,814
Market Cap
629.18B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 58.49B | 5.00B | 9.35% |
Mar 31, 2023 | 53.49B | 4.35B | 8.86% |
Mar 31, 2022 | 49.13B | 6.03B | 14.00% |
Mar 31, 2021 | 43.10B | 2.17B | 5.30% |
Mar 31, 2020 | 40.93B | 4.15B | 11.27% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Zydus Lifesciences | 222.47B |
Apollo Hospitals Enterprise | 211.46B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |
Abbott India News
- 5 weeks ago - Abbott India shares surge 3% as net profit jumps 16% YoY to Rs 360.8 crore in Q3 - Business Upturn
- 7 weeks ago - Pharma stocks: Glenmark up 1.57%, Glaxo gains 1.31%, Mankind Pharma declines 2.84% - Business Upturn
- 2 months ago - Pharma Stocks Today: Biocon surges 4.41%, Mankind Pharma up 1.85%; Glaxo and Abbott India decline - Business Upturn
- 2 months ago - Stock Market Update, January 7: Apollo Hospitals, Apar Industries, Abbott India, Amber Enterprises and more hit 52-week highs today - Business Upturn
- 3 months ago - Pharma Stocks: Cipla down nearly 2%, Ajanta Pharma down 1.45%, Abbott India up 1.27% - Business Upturn
- 3 months ago - Abbott India launches 14-Valent Pneumococcal Conjugate vaccine offering broad protection for children - Business Upturn
- 4 months ago - Abbott India shares fall nearly 4% following Q2 results - Business Upturn
- 4 months ago - Abbott India Q2 FY25 Results: Revenue up 9.3% YoY to ₹1,632.67 crore, Net Profit rises 14.6% YoY - Business Upturn